首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1561499

2024-2032 年按產品、組件、應用、最終用戶和地區分類的重組 DNA 技術市場報告

Recombinant DNA Technology Market Report by Product, Component, Application, End User, and Region 2024-2032

出版日期: 2024年09月10日 | 出版商:

IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年，全球重組DNA技術市場IMARC Group達7,648億美元。基因工程和生物技術的不斷進步、對生物製藥的需求不斷成長、向個人化藥物的日益轉變以及慢性病患病率的上升主要推動了市場的成長。

重組DNA技術市場分析：

主要市場促進因素：改善不同健康狀況的需求不斷成長，加上診斷試劑盒、監測設備和新治療方法的開發而改進的治療策略，是推動市場成長的關鍵因素之一。
主要市場趨勢：快速的城市化、全球人口的成長、耕地的減少、糧食短缺的嚴重加劇以及基改作物的日益採用，正在不斷增加市場需求。此外，重組DNA技術與有效基因療法的整合，以正常基因取代缺陷基因，以及生產用於臨床研究、研究和疾病診斷的抗原特異性抗體，預計將在未來幾年推動市場成長。
競爭格局：一些著名的重組DNA 技術市場公司包括Amgen Inc、Cibus、F.Hoffmann-La Roche Ltd、GenScript、GlaxoSmithKline plc.、Horizon Discovery Group plc、Merck KGaA、New England Biolabs、Novo Nordisk A/ S、輝瑞公司、賽諾菲公司和 Syngene International Ltd (Biocon Limited) 等。
地理趨勢：根據重組DNA技術市場動態，在廣泛的研發活動、完善的醫療基礎設施和大量政府資助的推動下，北美在重組DNA技術市場中佔有顯著佔有率。此外，歐洲的成長得益於對研發的高度重視以及生物製藥的高度採用。
挑戰與機會：監管合規性的提高和主要參與者之間的激烈競爭正在阻礙市場的成長。然而，對環保且省油的起落架系統的需求不斷增加。製造商可以透過開發輕質材料和節能設計來利用這一趨勢。

重組DNA技術市場趨勢：

生物製藥需求不斷成長

對單株抗體、疫苗和胰島素等生物製藥的需求不斷成長是一個主要驅動力。例如，根據IMARC Group的數據，2023 年全球生物製藥市場規模將達到 3,005 億美元。 2032.重組 DNA 技術在這些產品的生產中至關重要，這些產品對於治療各種慢性疾病至關重要。這些因素預計將在未來幾年推動重組 DNA 技術市場的發展。

慢性病盛行率增加

癌症、糖尿病和心血管疾病等慢性疾病的盛行率不斷上升，是推動市場成長的重要因素之一。例如，根據 IDF 糖尿病地圖集（2021 年），20 至 79 歲的成年人中有 10.5% 患有糖尿病。此外，到 2045 年，每 8 人中就有 1 人（約 7.83 億人）患有糖尿病，增幅為 46%。重組 DNA 技術能夠生產必需的治療性蛋白質和激素，例如用於糖尿病管理的胰島素和用於貧血治療的促紅血球生成素。這些因素進一步積極影響重組DNA技術產業市場。

技術進步

CRISPR等基因編輯工具的不斷創新，正在提升重組DNA技術的精準度與應用範圍，並推動市場擴張。例如，2024年8月，一群德國研究人員開發了一種增強型CRISPR（成簇規則間隔短回文重複）技術，以解決和改善針對血液和實體瘤的CAR-T細胞療法中現有的障礙。 CRISPR 是一項獨特的技術，使遺傳學家和醫學研究人員能夠透過刪除、插入或改變 DNA 序列來編輯基因組的部分，從而增加重組 DNA 技術系統的市場收入。

The global recombinant DNA technology market size reached US$ 764.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,119.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The ongoing advancements in genetic engineering and biotechnology, the growing demand for biopharmaceuticals, increasing shift towards personalized medicines, and the rising prevalence of chronic diseases are primarily driving the market's growth.

Recombinant DNA Technology Market Analysis:

Major Market Drivers: The rising demand for improving different health conditions coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market.
Key Market Trends: Rapid urbanization, growing global population, reducing arable land, considerable rising food shortage, and increasing adoption of GMO crops, are escalating the market demand. In addition, the integration of recombinant DNA technology with effective gene therapy for replacing defective genes with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.
Competitive Landscape: Some of the prominent recombinant DNA technology market companies include Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A, and Syngene International Ltd (Biocon Limited), among many others.
Geographical Trends: According to the recombinant DNA technology market dynamics, North America holds a prominent share in the recombinant DNA technology market, driven by extensive research and development activities, well-established healthcare infrastructure, and significant government funding. Moreover, the growth in Europe is supported by a strong focus on research and development and high adoption of biopharmaceuticals.
Challenges and Opportunities: Rising regulatory compliances and high competition among key players are hampering the market growth. However, there is an increasing demand for environmentally friendly and fuel-efficient landing gear systems. Manufacturers can capitalize on this trend by developing lightweight materials and energy-efficient designs.

Recombinant DNA Technology Market Trends:

Rising Demand for Biopharmaceuticals

The rising demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and insulin, is a major driver. For instance, according to IMARC, the global biopharmaceutical market size reached US$ 300.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 643.9 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032. Recombinant DNA technology is pivotal in the production of these products, which are essential for treating various chronic diseases. These factors are expected to propel the recombinant DNA technology market in the coming years.

Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is one of the significant factors driving the market's growth. For instance, according to the IDF Diabetes Atlas (2021), 10.5% of adults aged 20 to 79 suffer from diabetes. Also, by 2045, one in every eight persons, or roughly 783 million, will have diabetes, representing a 46% rise. Recombinant DNA technology enables the production of essential therapeutic proteins and hormones, such as insulin for diabetes management and erythropoietin for anemia treatment. These factors are further positively influencing the recombinant DNA technology industry market.

Technological Advancements

Continuous technological innovations, such as CRISPR and other gene-editing tools, are enhancing the precision and application scope of recombinant DNA technology, driving the market expansion. For instance, in August 2024, a group of German researchers developed an enhanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technique to solve and improve existing obstacles in CAR-T cell therapy that targets both blood and solid tumors. CRISPR is a unique technology that enables geneticists and medical researchers to edit portions of the genome by removing, inserting, or changing DNA sequences, thereby boosting the recombinant DNA technology systems market revenue.

Global Recombinant DNA Technology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global recombinant DNA technology market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, component, application, and end user.

Breakup by Product:

Medical
- Therapeutic Agent
- Human Protein
- Vaccines
Non-Medical
- Biotech Crops
- Specialty Chemicals
- Others

The report has provided a detailed breakup and analysis of the recombinant DNA technology market based on the product. This includes medical (therapeutic agent, human protein, and vaccines), and non-medical (biotech crops, specialty chemicals, and others).

According to the recombinant DNA technology market outlook, recombinant DNA technology enables the development of gene therapies to treat genetic disorders like cystic fibrosis, hemophilia, and muscular dystrophy. This technology has revolutionized the production of human insulin, making it more accessible for diabetic patients. While crops like Bt cotton, Roundup Ready soybeans, and Golden Rice have been developed using rDNA technology to enhance resistance to pests, herbicides, and to improve nutritional content.

Breakup by Component:

Expression System
Cloning Vector

The report has provided a detailed breakup and analysis of the recombinant DNA technology market based on the component. This includes expression system and cloning vector.

According to the recombinant DNA technology market overview, an expression system refers to the host organism and the molecular machinery used to produce recombinant proteins. It includes the host cells, the vectors, and the regulatory sequences necessary for gene expression. While a cloning vector is a DNA molecule used to carry foreign genetic material into a host cell, where it can be replicated and/or expressed. It is used in the development of genetically modified crops with desirable traits such as pest resistance and improved nutritional content.

Breakup by Application:

Food and Agriculture
Health and Disease
Environment
Others

A detailed breakup and analysis of the recombinant DNA technology market based on application has also been provided in the report. This includes food and agriculture, health and disease, environment, and others.

Recombinant DNA technology is used to develop genetically modified (GM) crops with desirable traits such as increased yield, pest resistance, herbicide tolerance, and improved nutritional content. This is crucial for meeting the food demands of a growing global population. Apart from this, in health and disease, it enables the production of insulin, growth hormones, monoclonal antibodies, and vaccines. The demand for effective and affordable biopharmaceuticals drives this sector. Besides this, it is also used to engineer microorganisms that can break down pollutants and toxins in the environment. This helps in cleaning up oil spills, heavy metals, and other environmental contaminants.

Breakup by End User:

Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Others

A detailed breakup and analysis of the recombinant DNA technology market based on end user has also been provided in the report. This includes biotechnology and pharmaceutical companies, academic and government research institutes, and others.

In biotechnology and pharmaceutical companies, recombinant DNA technology is used to produce human insulin in bacteria, which is a major advancement over previous methods using animal insulin. Companies use rDNA to develop monoclonal antibodies for the treatment of various diseases, including cancer and autoimmune disorders. While government research institutes like the CDC use rDNA technology to monitor and study pathogens, enabling rapid response to outbreaks and epidemics.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

According to the recombinant DNA technology market statistics, North America is one of the prominent regions for rDNA technology due to significant investments in biotechnology and pharmaceuticals. Moreover, Europe has a well-established biotechnology sector, particularly in countries like Germany, France, and the UK. The growth of the European region is driven by the strong collaboration between academic institutions, research institutes, and industry.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

Amgen Inc
Cibus
F.Hoffmann-La Roche Ltd
GenScript
GlaxoSmithKline plc.
Horizon Discovery Group plc
Merck KGaA
New England Biolabs
Novo Nordisk A/S
Pfizer Inc.
Sanofi S.A
Syngene International Ltd (Biocon Limited)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recombinant DNA Technology Market Recent Developments:

August 2024: German researchers developed an enhanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technique to solve and improve existing obstacles in CAR-T cell therapy that targets both blood and solid tumors.
July 2024: Scientists at the CSIR-Institute of Genomics and Integrative Biology in New Delhi developed an upgraded genome-editing device that can modify DNA more precisely and efficiently.
February 2024: Belgian researchers from the VIB-KU Leuven Center for Microbiology and the VIB-UGent Center for Plant Systems Biology created a new toolbox comprising 16 different short DNA sequences that may initiate controlled and selective recombination processes in any genome.

Key Questions Answered in This Report:

How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global recombinant DNA technology market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the component?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global recombinant DNA technology market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Recombinant DNA Technology Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Medical
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Therapeutic Agent
  - 6.1.2.2 Human Protein
  - 6.1.2.3 Vaccines
- 6.1.3 Market Forecast
6.2 Non-Medical
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Biotech Crops
  - 6.2.2.2 Specialty Chemicals
  - 6.2.2.3 Others
- 6.2.3 Market Forecast

7 Market Breakup by Component

7.1 Expression System
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Cloning Vector
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Application

8.1 Food and Agriculture
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Health and Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Environment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Biotechnology and Pharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Amgen Inc
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Cibus
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 F.Hoffmann-La Roche Ltd
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 SWOT Analysis
- 15.3.4 GenScript
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 GlaxoSmithKline plc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Horizon Discovery Group plc
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Merck KGaA
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 New England Biolabs
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Novo Nordisk A/S
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Sanofi S.A
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Syngene International Ltd (Biocon Limited)
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2023
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2023
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2023
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2023
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2023
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2023
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

全球基因重組技術市場按產品類型、應用、最終用戶和地區分類

重組 DNA 技術市場規模、佔有率和成長分析（按產品、組件、應用、最終用途和地區）- 產業預測 2025-2032

重組 DNA 技術市場規模、佔有率和趨勢分析報告：按產品、組件、應用、最終用途和細分市場進行預測，2024-2030 年

重組 DNA 技術市場，按組件、按應用、最終用戶、按國家和地區分類 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

FAQ

2024-2032 年按產品、組件、應用、最終用戶和地區分類的重組 DNA 技術市場報告

Recombinant DNA Technology Market Report by Product, Component, Application, End User, and Region 2024-2032

重組DNA技術市場分析：

重組DNA技術市場趨勢：

目錄

第1章：前言

第 2 章：範圍與方法

第 3 章：執行摘要

第 4 章：簡介

第 5 章：全球重組 DNA 技術市場

第 6 章：市場區隔：依產品

第 7 章：市場區隔：按組成部分

第 8 章：市場區隔：按應用

第 9 章：市場區隔：按最終用戶

第 10 章：市場區隔：按地區

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格分析

第15章：競爭格局